Serum from COVID-19 patients promotes endothelial cell dysfunction through protease-activated receptor 2.
Vieceli Dalla Sega F, Fortini F, Licastro D, Monego SD, Degasperi M, Ascierto A, Marracino L, Severi P, D'Accolti M, Soffritti I, Brambilla M, Camera M, Tremoli E, Contoli M, Spadaro S, Campo G, Ferrari R, Caselli E, Rizzo P.
Vieceli Dalla Sega F, et al. Among authors: monego sd.
Inflamm Res. 2024 Jan;73(1):117-130. doi: 10.1007/s00011-023-01823-y. Epub 2023 Dec 20.
Inflamm Res. 2024.
PMID: 38117300